Checkmate Pharmaceuticals Inc (CMPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-1991 | 03-1990 | |
| Sales | 163,951 | 163,951 |
| Cost of Goods | 148,472 | 148,472 |
| Gross Profit | 15,479 | 15,479 |
| Operating Expenses | 9,759 | 9,759 |
| Operating Income | 5,720 | 5,720 |
| Interest Expense | 4,411 | 4,411 |
| Other Income | -828 | -828 |
| Pre-tax Income | 481 | 481 |
| Income Tax | 264 | 264 |
| Net Income Continuous | 217 | 217 |
| Net Income | $217 | $217 |
| EBITDA(a) | $7,877 | $7,877 |